Tidal Investments LLC Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tidal Investments LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 18.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,575 shares of the medical equipment provider's stock after selling 4,359 shares during the period. Tidal Investments LLC's holdings in Intuitive Surgical were worth $9,617,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth $26,000. Godsey & Gibb Inc. lifted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 35 shares during the period. LGT Financial Advisors LLC boosted its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after acquiring an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new position in Intuitive Surgical during the second quarter worth about $37,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on ISRG. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Piper Sandler restated an "overweight" rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Citigroup boosted their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a research report on Wednesday. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $550.28.

Intuitive Surgical Trading Down 0.6 %

Shares of NASDAQ ISRG traded down $3.11 during trading on Friday, reaching $541.61. The company had a trading volume of 400,419 shares, compared to its average volume of 1,436,665. Intuitive Surgical, Inc. has a twelve month low of $320.26 and a twelve month high of $556.23. The stock has a 50-day moving average price of $520.67 and a two-hundred day moving average price of $477.52. The stock has a market capitalization of $192.91 billion, a PE ratio of 87.58, a price-to-earnings-growth ratio of 5.35 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.